XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V. Nov 21, 2025 7:45am EST
XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements Nov 12, 2025 7:30am EST
XOMA Royalty to Present at H.C. Wainwright 27th Annual Global Investment Conference Sep 03, 2025 7:30am EDT
Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share Aug 20, 2025 8:49am EDT
XOMA Royalty Reports Second Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements Aug 13, 2025 7:30am EDT
